News – Page 1074 – Endpoints News

A better approach to growth factors? Scholar Rock raises $47M on SMA promise

8 years ago

Microsoft, Google back DNAnexus' Big Data work with $58M; Novartis, Temasek back $50M round for Pear’s med apps

8 years ago

Chinese dealmaking: SARI nabs Italy’s NMS Group for $362M; Inovio retools deal with ApolloBio

8 years ago

Star drugs like BMS' Opdivo, AstraZeneca's Lynparza will get speedy OKs in China this year, new report predicts

8 years ago

Ex-Pfizer CEO's startup Centrexion gets $67M for PhIII painkiller

8 years ago

Celgene vet Barer lines up a $23M startup round for next-gen I/O tech out of Johns Hopkins

8 years ago

In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M

8 years ago

The class of 2017's winners and losers: A year of 'nonstop scientific achievements' raises troubling issues

8 years ago

J&J’s big blockbuster hopeful esketamine scores high for major depression — but side effects haunt results

8 years ago

On a deal spree, Mallinckrodt bags Sucampo and two late-stage rare disease drugs for $1.2B

8 years ago

Novartis' Tafinlar/Mekinist combo for melanoma gets priority review designation; Fosun Pharma backs joint venture's ...

8 years ago

Synergy CEO passes torch to CCO Troy Hamilton; President Steven Kafka resigns from Foundation; AbbVie vet John ...

8 years ago

Denied: FDA rejects Agile's contraception patch for second time

8 years ago

Celgene shares sink after another PhIII lymphoma flop and J&J steps up for the late-stage BCMA race

8 years ago

The FDA just approved the 46th new drug of the year — a record high for the past decade

8 years ago

Roche lines up at the FDA's 10-yard line with $1.7B Ignyta buyout

8 years ago

J&J wows with a $350M cash deal to partner on CAR-T with Legend, a one-time unknown until its star turn at ASCO

8 years ago

Following cancer combo deal with Bristol-Myers, Taris gets $25M Series B

8 years ago

Tracon inks deal with Ambrx to develop cancer drug in China; Roche wins consecutive approvals in EU and US

8 years ago

Kymriah, Yescarta found 'cost-effective' in treating cancer, despite high price

8 years ago

Looking for an early success in PhII Alzheimer’s study, Biogen and Eisai just racked up the latest setback

8 years ago

Google backs a $60M transition round for FLX’s switch to a CCR4 strategy

8 years ago

Merck, Pfizer make a late — very late — arrival at the SGLT2 party for diabetes

8 years ago

Backed by Henri Termeer estate, Aura raises $30M for work to prevent blindness in eye cancer patients

8 years ago

First page Previous page 1071 1072 107310741075 1076 1077 Next page Last page